KR20090076434A - 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제 - Google Patents
그라니세트론을 함유한 매트릭스 형태의 경피 흡수제 Download PDFInfo
- Publication number
- KR20090076434A KR20090076434A KR1020080002388A KR20080002388A KR20090076434A KR 20090076434 A KR20090076434 A KR 20090076434A KR 1020080002388 A KR1020080002388 A KR 1020080002388A KR 20080002388 A KR20080002388 A KR 20080002388A KR 20090076434 A KR20090076434 A KR 20090076434A
- Authority
- KR
- South Korea
- Prior art keywords
- matrix
- granisetron
- acrylate polymer
- comparative example
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
피부 흡수도(㎍/㎠/hr) | |
실시예 1 | 15.01 |
실시예 2 | 10.93 |
실시예 3 | 11.68 |
실시예 4 | 10.61 |
실시예 5 | 13.21 |
실시예 6 | 12.34 |
실시예 7 | 13.19 |
실시예 8 | 11.65 |
실시예 9 | 11.04 |
실시예 10 | 12.77 |
실시예 11 | 12.11 |
실시예 12 | 13.79 |
실시예 13 | 12.84 |
실시예 14 | 13.77 |
비교예 1 | 2.90 |
비교예 2 | 2.73 |
비교예 3 | 3.90 |
비교예 4 | 0.03 |
비교예 5 | 1.41 |
비교예 6 | 0.51 |
비교예 7 | 4.70 |
비교예 8 | 10.49 |
비교예 9 | 9.94 |
비교예 10 | 10.47 |
비교예 11 | 10.59 |
Claims (4)
- 그라니세트론을 유효성분으로 함유하는 매트릭스 형태의 경피흡수제제에 있어서, 상기 매트릭스에 히드록실기를 가진 아크릴레이트 고분자와 관능기가 없는 아크릴레이트 고분자가 20-99: 1-80 비율로 혼합된 점착제 및 폴리글리세릴-3 올레이트 (polyglyceryl-3 oleate), 폴리에틸렌글리콜-20 아몬드 글리세라이드(PEG-20 almond glyceride), 폴리에틸렌글리콜-12 팜 커넬 글리세라이드(PEG-12 palm kernel glyceride), 이소프로필 미리스테이트, 올레일 알코올(oleyl alcohol) 중에서 선택되는 1종 이상의 투과촉진제를 함유하는 것을 특징으로 하는 매트릭스 형태의 그라니세트론 경피 흡수제제.
- 제1항에 있어서, 그라니세트론의 함량은 배면층과 이형지를 제외한 메트릭스층 총중량의 1 내지 6 중량% 임을 특징으로 하는 매트릭스 형태의 그라니세트론 경피 흡수제제.
- 제1항 또는 2항에 있어서, 투과촉진제의 함량은 배면층과 이형지를 제외한 메트릭스층 총중량의 0.1 내지 25 중량% 임을 특징으로 하는 매트릭스 형태의 그라니세트론 경피 흡수제제.
- 제3항에 있어서, 배면층은 폴리에스테르, 폴리프로필렌, 폴리에틸렌, 에틸렌 비닐아세테이트, 폴리우레탄 중에서 선택되는 고분자막으로 구성된 것을 특징으로 하는 매트릭스 형태의 그라니세트론 경피 흡수제제.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080002388A KR100929560B1 (ko) | 2008-01-09 | 2008-01-09 | 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제 |
US12/811,003 US9066886B2 (en) | 2008-01-09 | 2008-08-22 | Transdermal drug delivery system containing granisetron |
PCT/KR2008/004900 WO2009088142A1 (en) | 2008-01-09 | 2008-08-22 | Transdermal drug delivery system containing granisetron |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080002388A KR100929560B1 (ko) | 2008-01-09 | 2008-01-09 | 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090076434A true KR20090076434A (ko) | 2009-07-13 |
KR100929560B1 KR100929560B1 (ko) | 2009-12-03 |
Family
ID=40853239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080002388A KR100929560B1 (ko) | 2008-01-09 | 2008-01-09 | 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제 |
Country Status (3)
Country | Link |
---|---|
US (1) | US9066886B2 (ko) |
KR (1) | KR100929560B1 (ko) |
WO (1) | WO2009088142A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210105596A (ko) | 2020-02-19 | 2021-08-27 | 신신제약 주식회사 | 그라니세트론을 함유하는 경피흡수제제 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI541246B (zh) | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
AP3030A (en) | 2010-04-30 | 2014-11-30 | Teikoku Pharma Usa Inc | Propynylaminoindan transdermal compositions |
AU2013338243B2 (en) | 2012-11-02 | 2016-09-29 | Teikoku Seiyaku Co., Ltd. | Propynylaminoindan transdermal compositions |
GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
EP3206673A1 (en) | 2014-10-17 | 2017-08-23 | Fidia Farmaceutici S.p.A. | Dermal therapeutic system with high adhesivity |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5858340A (en) * | 1992-05-22 | 1999-01-12 | The Procter & Gamble Company | Cosmetic compositions |
AU3170697A (en) | 1997-05-30 | 1998-12-30 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery device for the delivery of tropisetron or granisetron |
US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
GB0119012D0 (en) * | 2001-08-03 | 2001-09-26 | Strakan Group Plc | Transdermal delivery of drugs |
NZ537360A (en) * | 2002-06-25 | 2006-09-29 | Acrux Dds Pty Ltd | Transdermal delivery rate control using amorphous pharmaceutical compositions |
JP4792193B2 (ja) * | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | 貼付剤 |
GB0302662D0 (en) | 2003-02-05 | 2003-03-12 | Strakan Ltd | Transdermal granisetron |
WO2005123046A1 (en) * | 2004-06-15 | 2005-12-29 | Amorepacific Corporation | Novel transdermal preparation and its producing method |
JP2008511663A (ja) * | 2004-09-01 | 2008-04-17 | ネクスメツド・ホールデイングス・インコーポレイテツド | 経皮制吐送達系、そのための方法および組成物 |
CA2583340C (en) * | 2004-10-08 | 2015-09-08 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
US20060263421A1 (en) | 2005-05-18 | 2006-11-23 | Abeille Pharmaceuticals Inc | Transdermal Method and Patch for Nausea |
-
2008
- 2008-01-09 KR KR1020080002388A patent/KR100929560B1/ko active IP Right Grant
- 2008-08-22 WO PCT/KR2008/004900 patent/WO2009088142A1/en active Application Filing
- 2008-08-22 US US12/811,003 patent/US9066886B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210105596A (ko) | 2020-02-19 | 2021-08-27 | 신신제약 주식회사 | 그라니세트론을 함유하는 경피흡수제제 |
Also Published As
Publication number | Publication date |
---|---|
KR100929560B1 (ko) | 2009-12-03 |
US9066886B2 (en) | 2015-06-30 |
US20100285133A1 (en) | 2010-11-11 |
WO2009088142A1 (en) | 2009-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016202212B2 (en) | Stabilized transdermal drug delivery system | |
AU2017213569B2 (en) | Transdermal therapeutic system for administering an active substance | |
TWI253349B (en) | Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder | |
CA2098196C (en) | Method and systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers | |
JP6060213B2 (ja) | 外用医薬組成物を用いた貼付剤 | |
JP5615697B2 (ja) | β遮断剤の安定化組成物およびそれを用いた経皮吸収製剤 | |
EP2687205B1 (en) | Fentanyl transdermal patch | |
KR101192969B1 (ko) | 도네페질을 함유하는 경피흡수제제 | |
KR100929560B1 (ko) | 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제 | |
CN102470131B (zh) | 含有芬太尼的外用粘合剂制剂 | |
JP5813652B2 (ja) | 経皮吸収型製剤 | |
EP0435199B2 (en) | Acrylic gel material and acrylic gel preparation | |
KR102499141B1 (ko) | 수면장애 치료용 경피흡수제제 | |
EP1711170B1 (en) | Transdermal delivery device for dihydropyridine type calcium antagonists containing two fatty acids | |
WO2020260727A1 (en) | Transdermal therapeutic system containing agomelatine | |
KR100610626B1 (ko) | 고 효능의 신경이완제를 갖는 경피성 치료 시스템 | |
KR20090101579A (ko) | 펜타닐을 함유한 경피 흡수제 | |
KR101353478B1 (ko) | 펜타닐을 함유하는 경피투여용 패취 제제 | |
KR100439659B1 (ko) | 툴로부테롤을 함유하는 경피흡수용 패취제 | |
JPWO2012057220A1 (ja) | 経皮吸収型製剤 | |
KR102537845B1 (ko) | 그라니세트론을 함유하는 경피흡수제제 | |
KR20050046350A (ko) | 펜타닐을 유효성분으로 함유하는 경피투여제제 | |
JP2019034905A (ja) | デヒドロ酢酸含有経皮吸収製剤 | |
KR20150064842A (ko) | 케토티펜 또는 그 염을 함유하는 경피흡수제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121129 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20131021 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20141017 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20151103 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20161124 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20171127 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20181023 Year of fee payment: 10 |